These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 17074773)

  • 21. Treatment of atrial fibrillation: time for change?
    Campbell TJ
    Med J Aust; 1992 Jul; 157(2):78-80. PubMed ID: 1630394
    [No Abstract]   [Full Text] [Related]  

  • 22. [Should we add antiplatelet therapy to oral anticoagulation in patients with atrial fibrillation and vascular disease? Review of available evidence].
    Andreu JM; Roldán V; García-Navarro M; Ruipérez JA; Valdés M; Marín F
    Arch Cardiol Mex; 2012; 82(3):248-51. PubMed ID: 23021363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adherence to guidelines and mortality in atrial fibrillation.
    Díez-Manglano J; Gomes-Martín J; Al-Cheikh-Felices P; Pérez SI; Díez-Angulo R; Clemente-Sarasa C
    Int J Cardiol; 2014 Sep; 176(2):430-6. PubMed ID: 25127960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.
    Ruiz-Nodar JM; Marín F; Hurtado JA; Valencia J; Pinar E; Pineda J; Gimeno JR; Sogorb F; Valdés M; Lip GY
    J Am Coll Cardiol; 2008 Feb; 51(8):818-25. PubMed ID: 18294566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China.
    Hu D; Sun Y
    J Am Coll Cardiol; 2008 Sep; 52(10):865-8. PubMed ID: 18755352
    [No Abstract]   [Full Text] [Related]  

  • 26. Combining antiplatelet and anticoagulant therapies.
    Holmes DR; Kereiakes DJ; Kleiman NS; Moliterno DJ; Patti G; Grines CL
    J Am Coll Cardiol; 2009 Jul; 54(2):95-109. PubMed ID: 19573725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antithrombotic Therapy After Percutaneous Coronary Intervention in Atrial Fibrillation.
    Godino C; Pivato CA; Rubino C; Russi A; Cera M; Margonato A
    Am J Cardiol; 2020 Aug; 129():122-124. PubMed ID: 32540165
    [No Abstract]   [Full Text] [Related]  

  • 28. Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range.
    Connolly SJ; Pogue J; Eikelboom J; Flaker G; Commerford P; Franzosi MG; Healey JS; Yusuf S;
    Circulation; 2008 Nov; 118(20):2029-37. PubMed ID: 18955670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.
    Fuster V; Rydén LE; Cannom DS; Crijns HJ; Curtis AB; Ellenbogen KA; Halperin JL; Le Heuzey JY; Kay GN; Lowe JE; Olsson SB; Prystowsky EN; Tamargo JL; Wann S; Smith SC; Jacobs AK; Adams CD; Anderson JL; Antman EM; Halperin JL; Hunt SA; Nishimura R; Ornato JP; Page RL; Riegel B; Priori SG; Blanc JJ; Budaj A; Camm AJ; Dean V; Deckers JW; Despres C; Dickstein K; Lekakis J; McGregor K; Metra M; Morais J; Osterspey A; Tamargo JL; Zamorano JL; ; ; ; ;
    Europace; 2006 Sep; 8(9):651-745. PubMed ID: 16987906
    [No Abstract]   [Full Text] [Related]  

  • 30. [The European Society of Cardiology (ESC) guidelines for percutaneous coronary interventions (PCI). Three case reports].
    Silber S; Richartz BM; Brilmayer M;
    Herz; 2006 Dec; 31(9):836-46, 848. PubMed ID: 17180646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current recommendations for anticoagulant therapy in patients with valvular heart disease and atrial fibrillation: the ACC/AHA and ESC/EACTS Guidelines in Harmony…but not Lockstep!
    Erwin JP; Iung B
    Heart; 2018 Jun; 104(12):968-970. PubMed ID: 29326109
    [No Abstract]   [Full Text] [Related]  

  • 32. [Drug therapy of patients with arrhythmia].
    Sugimoto T
    Nihon Naika Gakkai Zasshi; 1992 Mar; 81(3):407-11. PubMed ID: 1607805
    [No Abstract]   [Full Text] [Related]  

  • 33. Oral anticoagulants vs. antiplatelet therapy.
    Hitzeman N; Applebaum S
    Am Fam Physician; 2008 May; 77(9):1250-2. PubMed ID: 18540488
    [No Abstract]   [Full Text] [Related]  

  • 34. Combination anticoagulant and antiplatelet therapy in atrial fibrillation patients.
    Lip GY; Lane DA
    Rev Esp Cardiol; 2009 Sep; 62(9):972-5. PubMed ID: 19712617
    [No Abstract]   [Full Text] [Related]  

  • 35. Optimizing anticoagulant therapy.
    Wheatley M; Cox JL; Nemis-White J
    Can Nurse; 2003 Jun; 99(6):16-9. PubMed ID: 12858669
    [No Abstract]   [Full Text] [Related]  

  • 36. [ROCKET AF].
    Tiefenbacher CP
    Herz; 2011 Mar; 36(2):149-50. PubMed ID: 21424349
    [No Abstract]   [Full Text] [Related]  

  • 37. Heart groups release partial update to atrial fibrillation guidelines.
    Traynor K
    Am J Health Syst Pharm; 2011 Feb; 68(4):284, 286. PubMed ID: 21289319
    [No Abstract]   [Full Text] [Related]  

  • 38. Advances in cardiology: clinical trial update.
    Howe AJ; Shand JA; Menown IB
    Future Cardiol; 2011 May; 7(3):299-310. PubMed ID: 21627472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee.
    Antman EM; Hand M; Armstrong PW; Bates ER; Green LA; Halasyamani LK; Hochman JS; Krumholz HM; Lamas GA; Mullany CJ; Pearle DL; Sloan MA; Smith SC; ; Anbe DT; Kushner FG; Ornato JP; Jacobs AK; Adams CD; Anderson JL; Buller CE; Creager MA; Ettinger SM; Halperin JL; Hunt SA; Lytle BW; Nishimura R; Page RL; Riegel B; Tarkington LG; Yancy CW
    Circulation; 2008 Jan; 117(2):296-329. PubMed ID: 18071078
    [No Abstract]   [Full Text] [Related]  

  • 40. Antiplatelet therapy in percutaneous coronary intervention: a critical review of the 2007 AHA/ACC/SCAI guidelines and beyond.
    Cohen M
    Catheter Cardiovasc Interv; 2009 Oct; 74(4):579-97. PubMed ID: 19472347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.